Oxford University

Timelines
AstraZeneca vaccine's single dose reduces death risk by 80%: Data

11 May 2021

AstraZeneca vaccine's single dose reduces death risk by 80%: Data

A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said Monday, citing data from the vaccine's rollout.

15 Mar 2021

#OxfordUniversity racism row: India to raise the issue when required

Weighing in on the Oxford University racism row, External Affairs Minister, S Jaishankar, on Monday said India will take up the matter with the UK when required. He was responding to BJP MP Ashwini Vaishnaw's query in the Parliament.

21 Jan 2021

Five killed in Serum Institute fire; Maharashtra government orders probe

The Maharashtra government has ordered a probe into the fire that broke out at the Serum Institute of India in Pune on Thursday, killing at least five people.

19 Jan 2021

Maldives to become first foreign country to receive Covishield doses

Maldives is set to become the first foreign country to receive COVID-19 vaccines from India. The Asian country will reportedly receive a consignment of Covishield doses on Wednesday.

17 Jan 2021

Meet India's frontline workers who received first COVID-19 vaccine shots

On Saturday, India launched its COVID-19 vaccination drive, inoculating 1.91 lakh people on the first day alone.

10 Jan 2021

Delhi identifies 89 sites for COVID-19 vaccination drive: Health Minister

The Delhi government has identified 89 sites for the COVID-19 vaccination drive in the national capital, Health Minister Satyendar Jain said on Sunday.

08 Jan 2021

Severe side-effects after COVID-19 vaccine: What are your legal options?

India is looking forward to launching a massive COVID-19 vaccination drive with two vaccines that have been granted emergency use authorization (EUA).

07 Jan 2021

COVID-19 vaccine transport to start soon; government readies plan

The central government has prepared a detailed draft for the transport of vaccines across India ahead of a nationwide roll-out.

07 Jan 2021

Ahead of nationwide exercise, COVID-19 vaccine dry run in Haryana

A dry run of the COVID-19 vaccine roll-out was conducted in Haryana on Thursday, a day before the exercise will be conducted across India.

05 Jan 2021

SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.

04 Jan 2021

Bharat Biotech allowed COVAXIN trials on children aged 12+

Hyderabad-based pharmaceutical company Bharat Biotech has been allowed to conduct clinical trials for its COVID-19 vaccine on children above the age of 12.

03 Jan 2021

'Finally paid off,' says Adar Poonawalla after Covishield gets approval

Serum Institute of India's (SII) chief Adar Poonawalla today wished everyone a happy new year along with a great announcement.

03 Jan 2021

All you need to know about vaccines approved in India

Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.

03 Jan 2021

SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI

Two COVID-19 vaccines, Covishield and COVAXIN, have been granted emergency approval for use in India, the Drugs Controller General of India (DCGI) Dr. VG Somani said on Sunday.

03 Jan 2021

Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod

A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.

31 Dec 2020

UK's approval to Oxford-AstraZeneca vaccine paves way for India

The United Kingdom on Wednesday approved the vaccine developed by Oxford University and the British-Swedish pharmaceutical company AstraZeneca, giving the vaccine an endorsement that will likely be considered by Indian drug regulators.

30 Dec 2020

After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK

The COVID-19 vaccine developed by Oxford University and AstraZeneca has been approved for use in the United Kingdom.

28 Dec 2020

Centre extends COVID-19 surveillance guidelines till January 31

The Ministry of Home Affairs on Monday extended guidelines for COVID-19 surveillance, containment, and caution till January 31, 2021.

28 Dec 2020

Oxford/AstraZeneca vaccine should be effective against new variant: Report

The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, a UK media report said on Sunday.

26 Dec 2020

Dharavi logs zero coronavirus cases for first time since April

Labeled as a coronavirus hotspot once, Dharavi, believed to be the largest slum in Asia, reported no new coronavirus cases on Friday since April 1 when the first infection came to light.

22 Dec 2020

Russia, AstraZeneca to test combination of COVID-19 shots

Developers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.

18 Dec 2020

COVID-19 vaccine: India to produce 300 million Sputnik V doses

India will reportedly produce around 300 million doses of the Russian COVID-19 vaccine called Sputnik V.

09 Dec 2020

Oxford-AstraZeneca release final-stage trial results, coronavirus vaccine labeled safe

The University of Oxford and pharmaceutical firm AstraZeneca became the first coronavirus vaccine developers to release their final-stage clinical trial data.

08 Dec 2020

COVID-19 vaccine may get license in coming weeks: Health Ministry

India may license some COVID-19 vaccines in the next few weeks, the Union Health Ministry said on Tuesday.

08 Dec 2020

COVID-19 vaccine: 90-year-old woman receives first Pfizer shot in UK

A 90-year-old woman in the United Kingdom has become the world's first person to receive the COVID-19 vaccine developed by Pfizer and BioNTech outside of clinical trials.

02 Dec 2020

Trial will continue: Centre on SII vaccine's "adverse reaction" claims

With the coronavirus vaccine trials being conducted by Serum Institute of India (SII) being shrouded in controversy after a participant complained of an "adverse reaction," the Centre on Tuesday said there's no need to stop the process.

01 Dec 2020

SII says Covishield 'safe' after trial participant sends legal notice

The Serum Institute of India (SII) on Tuesday said that its COVID-19 vaccine candidate was "safe and immunogenic," in response to allegations that a trial participant developed serious side-effects after being administered the dose.

30 Nov 2020

SII to sue vaccine trial participant for Rs. 100 crore

The Serum Institute of India (SII) has said that it will seek Rs. 100 crore in damages from a COVID-19 vaccine trial participant for complaining about side-effects.

28 Nov 2020

Applying for Covishield's emergency approval in 2 weeks: SII

The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.

28 Nov 2020

PM to visit three cities to review coronavirus vaccine development

Prime Minister Narendra Modi will visit three cities today to review the coronavirus vaccine development and manufacturing process, his office revealed.

24 Nov 2020

Russia's Sputnik V at least 91% effective, early data suggests

The Russian vaccine for COVID-19, called Sputnik V, has been found at least 91% effective in the second interim analysis.

23 Nov 2020

Can launch 100 million vaccine doses by January-February, says Poonawalla

The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.

23 Nov 2020

Oxford's vaccine, India's best shot against coronavirus, is 70% effective

The coronavirus vaccine being developed by Oxford University and British pharma giant AstraZeneca is 70% effective, results from large-scale trials have shown, multiple reports said on Monday.

20 Nov 2020

Oxford vaccine to be available by April 2021 in India

Pune-based Serum Institute of India, which has partnered with Oxford University and British pharma giant AstraZeneca, plans to seek an emergency approval from the government of India next month, for providing the coronavirus vaccine to "corona warriors" and the elderly.

19 Nov 2020

Can deliver coronavirus vaccine in a few months: Health Minister

India's Health Minister Dr. Harsh Vardhan said today that deliveries of coronavirus vaccine will happen within a few months, adding that the country's scientists are way ahead in terms of research.

16 Nov 2020

Moderna's COVID-19 vaccine found to be 95% effective: Details here

American biotech company Moderna Therapeutics has announced that its COVID-19 vaccine was found to be nearly 95% effective in preventing the novel coronavirus disease.

16 Nov 2020

Claire Foy rewinds time with 'The Crown' Season 4 cameo

It has been a great rewind for the fans of Claire Foy, the actor who played the role of Queen Elizabeth II in the first two seasons of Netflix British empire drama The Crown.

14 Nov 2020

India to get 10cr COVID-19 vaccine doses by December: SII

The Serum Institute of India is hoping to produce 100 million (10 crore) doses of AstraZeneca and Oxford University's COVID-19 vaccine, CEO Adar Poonawalla said.

12 Nov 2020

COVISHIELD vaccine could be realistic solution to COVID-19 pandemic: ICMR

The Indian Council of Medical Research (ICMR) and Pune-based Serum Institute of India (SII) on Thursday announced the completion of enrollment of participants to the Phase-3 clinical trials for the potential COVID-19 vaccine COVISHIELD in India.

29 Oct 2020

Oxford's coronavirus vaccine could be available by December: Adar Poonawalla

In a welcome piece of development, Serum Institute of India's CEO Adar Poonawalla said on Wednesday that the coronavirus vaccine, being developed by Oxford University, could be available for use in India by December 2020.


Latest News

Features

Popular news

Download App
Stay Updated